Daniel Anderson

Professor
New IP

Department
Department of Chemical Engineering
Technology Areas
Biotechnology: DNA & RNA Editing, Biomedical Devices & Systems, Sensors & Monitoring, Synthetic Biology, Biomanufacturing / Chemicals & Materials: Catalysis & Synthesis, Nanotechnology & Nanomaterials, Polymers, Composites / Drug Discovery and Research Tools: Genomics & Proteomics, Cell Interrogation, Cell Lines & Organoids, Cell Culture / Therapeutics: Nucleic Acids, Small Molecules, Cell Based Therapy, Vaccines, Proteins & Antibodies, Regenerative Medicine / Drug Delivery: Microparticles & Nanoparticles, Vectors & Virus like Particles / Artificial Intelligence (AI) and Machine Learning (ML) / Sensing & Imaging: Imaging, Chemical & Radiation Sensing / Energy & Distribution: Electrochemical Devices / Biomaterials & Bioelectronics: Medical Device Coatings, Health Monitoring / Computer Science: Bioinformatics / Diagnostics: Assays

Pioneering smart materials for advancements in medical devices, drug delivery, and gene therapy, with a prolific publication record and significant impact across multiple disciplines.

Background and Experience

Daniel G. Anderson is a leading researcher in the fields of nanotherapeutics and biomaterials and has pioneered the development of smart materials. In addition to the Koch Institute, he holds appointments in MIT’s Department of Chemical Engineering, Institute for Medical Engineering and Science, and Harvard-MIT Division of Health Science and Technology. Anderson received a BA in mathematics and biology from the University of California at Santa Cruz and a PhD in molecular genetics from the University of California at Davis. Anderson’s work has led to advances in a range of areas, including medical devices, cell therapy, drug delivery, gene therapy and material science, and has resulted in the publication of more than 500 papers, patents, and patent applications. He is the recipient of the 2023 Wilhelm Exner Medal.

Awards and Honors

  • Work has resulted in the publication of more than 500 papers, patents, and patent applications
  • Wilhelm Exner Medal | 2023

Technologies

A Bioinspired Design of Self-Adjuvanted C3d-Fusion SARS-CoV-2 mRNA Vaccines

Technology / Case number: #23326
Robert Langer / Bowen Li / Allen Jiang / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Biodegradable Polymers for Messenger RNA Delivery to the Lung

Technology / Case number: #19314
Kevin Kauffman / James Kaczmarek / Asha Patel / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Structure-Guided Chemical Modification of Guide RNA and its Applications

Technology / Case number: #19175V
Hao Yin / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Crystalline and Amorphous Formulations Used to Deliver Anti-Fibrotic (and other) Compounds in Conjunction with Implanted Materials (Cells/Devices)

Technology / Case number: #18287J
Joshua Doloff / Shady Farah / Robert Langer / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery / Therapeutics
License

sgRNA Chemical Modification for Efficient Gene Editing

Technology / Case number: #17805V
Hao Yin / Robert Langer / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Ionizable Lipids for Messenger RNA Delivery

Technology, Tangible Property / Case number: #24861
Jacob Witten / Idris Raji / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery / Drug Discovery and Research Tools / Therapeutics
Impact Areas: Healthy Living
License

Cationic Lipidoids and Their Uses for Immunotherapy

Technology / Case number: #19803
Linxian Li / Yuxuan Huang / Lei Miao / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Therapeutics
License

Synthesis of Ester, Carbonate, and Carbamate-derived Novel Biodegradable Ionizable Lipids from Methyl Ricinoleate or Methyl 12-Hydroxystearate and its Applications

Technology / Case number: #23381Q
Luke Rhym / Bowen Li / Akiva Gordon / rajith manan / Jacob Witten / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Discovery and Research Tools / Therapeutics
License

Biodegradable Lipids and Formulations for Intramuscular, In Vitro, and Ex Vivo Transfection of mRNA

Technology / Case number: #23969J
Arnab Rudra / Akash Gupta / Kaelan Reed / Daniel Anderson
Technology Areas: Biotechnology / Chemicals & Materials / Drug Delivery / Drug Discovery and Research Tools / Therapeutics
License

Fusion Capsid Therapy for COVID-19 and Applies to Other Viruses: Universal "Dominant" Antiviral to Prevent Virus Evolution and Future Pandemics (DNA/RNA/Protein)

Technology, Tangible Property / Case number: #22801MH
Edward Stuart Boyden / Robert Langer / Alexi Choueiri / Yong Qian / Bowen Li / Daniel Anderson
Technology Areas: Chemicals & Materials / Drug Delivery / Therapeutics
Impact Areas: Healthy Living
License

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.